NCT03735368View on ClinicalTrials.gov

Dexmedetomidine and Pregabalin for Conscious Sedation During Cataract Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

October 30, 2019

Study Completion Date

November 29, 2019

Conditions
Conscious Sedation
Interventions
DRUG

Dexmedetomidine Injection

Dexmedetomidine Injection 1 μg/kg then 0.5-1 μg/kg/h infusion

DRUG

Placebo oral capsule

placebo oral capsules

DRUG

Pregabalin Oral Capsule

150 mg pregabalin Oral Capsule

DRUG

topical anesthesia

topical anesthesia of the eye by Benoxinate Hydrochloride 0.4% Eye Drops

Trial Locations (1)

32511

Faculty of Medicine, Cairo

All Listed Sponsors
lead

Abd-Elazeem Abd-Elhameed Elbakry

OTHER

NCT03735368 - Dexmedetomidine and Pregabalin for Conscious Sedation During Cataract Surgery | Biotech Hunter | Biotech Hunter